Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Press Release/Announcement

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings.

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; February 3. 2021.   

Save
Print
February 17, 2021

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; February 3. 2021. 
 

Recalls of medical products due to labeling errors are an established proactive safety strategy. This announcement highlights an anticoagulant packaging mistake that could result in dosing errors.

Save
Print
Cite
Citation

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; February 3. 2021.